Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large

Annual Review of Immunology

Volumn 24, Issue , 2006, Pages 353-389

  Beutler, Bruce ^a   Jiang, Zhengfan ^a   Georgel, Philippe ^a   Crozat, Karine ^a   Croker, Ben ^a   Rutschmann, Sophie ^a   Du, Xin ^a   Hoebe, Kasper ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Infection; Innate immunity; Mendelian genetics; Mutagenesis

Indexed keywords

ADAPTOR PROTEIN; B7 ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CD36 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED RNA; ETHYLNITROSOUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; MACROPHAGE ACTIVATING FACTOR; MUTAGENIC AGENT; MYELOID DIFFERENTIATION FACTOR 88; PROFILIN; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; GENE MUTATION; GENETIC ANALYSIS; GENOMICS; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION RESISTANCE; INNATE IMMUNITY; MAMMAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALS; ETHYLNITROSOUREA; HUMANS; IMMUNITY, NATURAL; INFECTION; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR STRUCTURE; MUTAGENS; MUTATION; PHENOTYPE; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS; VIRUS DISEASES;

EID: 33646183566     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.24.021605.090552     Document Type: Review

References (136)

1. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. 1988. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318:727-32
2. Lee SH, Girard S, Macina D, Busa M, Zafer A, et al. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42-45
3. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, et al. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-37
4. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, et al. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37:593-99
5. Lee SH, Zafer A, De Repentigny Y, Kothary R, Tremblay ML, et al. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197:515-26
6. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. 1996. Resistance to HIV-1 infection in Caucasian indhiduals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-25
7. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. 1997. Global distribution of the CCR5 gene 32-basepair deletion. Nat. Genet. 16:100-3
8. Pancer Z, Amemiya CT, Ehrhardt GR, Ceitlin J, Gartland GL, Cooper MD. 2004. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430:174-80
9. Beutler B, Crozat K, Koziol JA, Georgel P. 2005. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr. Opin. Immunol. 17:36-43
10. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83
11. Anderson KV, Bokla L, Nusslein-Volhard C. 1985. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42:791-98
12. Beutler B. 2004. Innate immunity: an overview. Mol. Immunol. 40:845-59
13. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW. 1998. Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-88
14. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-7
15. Beutler B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-63
16. Luderitz O, Galanos C, Lehmann V, Nurminen M, Rietschel ET, et al. 1973. Lipid A: chemical structure and biological activity. J. Infect. Dis. 128:29
17. Berczi I, Bertok L, Bereznai T. 1966. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 12:1070-71
18. Michalek SM, Moore RN, McGhee JR, Rosenstreich DL, Mergenhagen SE. 1980. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J. Infec. Dis. 141:55-63
19. Beutler B, Milsark IW, Cerami A. 1985. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 229:869-71
20. Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, et al. 2003. Central role for type I interferons and Tyk2 in lipopolysaccharide- induced endotoxin shock. Nat. Immunol. 4:471-77
21. Heppner G, Weiss DW. 1965. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J. Bacteriol. 90:696-703
22. Watson J, Riblet R. 1974. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J. Exp. Med. 140:1147-61
23. Watson J, Riblet R. 1975. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides. J. Immunol. 114:1462-68
24. Watson J, Riblet R, Taylor BA. 1977. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J. Immunol. 118:2088-93
25. Skidmore BJ, Chiller JM, Weigle WO, Riblet R, Watson J. 1976. Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J. Exp. Med. 143:143-50
26. Condie RM, Zak SJ, Good RA. 1955. Effect of meningococcal endotoxin on the immune response. Proc. Soc. Exp. Biol. Med. 90:355-60
27. Coutinho A, Meo T. 1978. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 7:17-24
28. O'Brien AD, Rosenstreich DL, Scher I, Campbell GH, MacDermott RP, Formal SB. 1980. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124:20-4
29. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C. 1984. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:839-44
30. Woods JP, Frelinger JA, Warrack G, Cannon JG. 1988. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect. Immun. 56:1950-55
31. d mice. FEMS Immunol. Med. Microbiol. 13:235-38
32. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171:35-47
33. Poltorak A, He X, Smirnova I, Liu M-Y, Van Huffel C, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-88
34. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, et al. 1994. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res. 1:27-35
35. Taguchi T, Mitcham JL, Dower SK, Sims JE, Testa JR. 1996. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genome 32:486-88
36. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-97
37. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-93
38. Rutschmann S, Kilinc A, Ferrandon D. 2002. Cutting edge: the Toll pathway is required for resistance to Gram-positive bacterial infections in Drosophila. J. Immunol. 168:1542-46
39. Chaturvedi MM, Higuchi M, Aggarwal BB. 1994. Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-κB: evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res. 13:309-13
40. Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, et al. 1997. Interleukin-18 activates NF-κB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234:454-57
41. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-81
42. Choe J, Kelker MS, Wilson IA. 2005. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309:581-85
43. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, et al. 2000. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408:111-15
44. Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ. 2003. Structural complementarity of Toll/interleukin-1 receptor identity regions in Toll-like receptors and the adaptors Mal and MyD88. J. Biol. Chem. 278:41443-51
45. Schneider DS, Hudson KL, Lin TY, Anderson KV. 1991. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev. 5:797-807
46. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, et al. 2005. CD36 is a sensor of diacylglycerides. Nature 433:523-27
47. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-33
48. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, et al. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667-72
49. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, et al. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14
50. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, et al. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-40
51. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, et al. 2005. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35:282-89
52. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-103
53. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200
54. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-29
55. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-31
56. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, et al. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101:5598-603
57. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-45
58. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, et al. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:9237-42
59. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection 3. Proc. Natl. Acad. Sci. USA 101:3516-21
60. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, et al. 2004. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-26
61. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-29
62. Takeuchi O, Hoshino K, Akira S. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to staphylococcus aureus infection. J. Immunol. 165:5392-96
63. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, et al. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107-19
64. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401
65. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281-86
66. Jude BA, Pobezinskaya Y, Bishop J, Parke S, Medzhitov RM, et al. 2003. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:573-78
67. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424:743-48
68. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-20
69. Crozat K, Beutler B. 2004. TLR7: A new sensor of viral infection. Proc. Natl. Acad. Sci. USA 101:6835-36
70. Ehl S, Bischoff R, Ostler T, Vollbracht S, Schulte-Monting J, et al. 2004. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34:1146-53
71. Youmans AS, Youmans GP. 1969. Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations. J. Bacterial. 99:42-50
72. Youmans GP, Youmans AS. 1969. Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs. J. Bacteriol. 97:134-39
73. Schmidtke JR, Johnson AG. 1971. Regulation of the immune system by synthetic polynucleotides. I. Characteristics of adjuvant action on antibody synthesis. J. Immunol. 106:1191-200
74. Capanna SL, Kong YM. 1974. Further studies on the prevention of tolerance induction by poly A:U. Immunology 27:647-53
75. Nauciel C, Fleck J, Martin JP, Mock M, Nguyen-Huy H. 1974. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response. Eur. J. Immunol. 4:352-56
76. Bultmann B, Finger H, Heymer B, Schachenmayr W, Hof H, Haferkamp O. 1975. Adjuvancy of streptococcal nucleic acids Z. Immunitatsforsch. Exp. Klin. Immunol. 148:425-30
77. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, et al. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303-13
78. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:5688-94
79. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, et al. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4:1223-29
80. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. 2003. Role of adapter TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-43
81. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, et al. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4:1144-50
82. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, et al. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201:915-23
83. Gallucci S, Lolkema M, Matzinger P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249-55
84. Kile BT, Hentges KE, Clark AT, Nakamura H, Salinger AP, et al. 2003. Functional genetic analysis of mouse chromosome 11. Nature 425:81-86
85. Concepcion D, Seburn KL, Wen G, Frankel WN, Hamilton BA. 2004. Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics 168:953-59
86. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. 1999. Mouse ENU mutagenesis. Hum. Mol. Genet. 8:1955-63
87. Sagai T, Hosoya M, Mizushina Y, Tamura M, Shiroishi T. 2005. Elimination of a long-range cis-regulatory module causes complete loss of limb-specific Shh expression and truncation of the mouse limb. Development 132:797-803
88. Sagai T, Masuya H, Tamura M, Shimizu K, Yada Y, et al. 2004. Phylogenetic conservation of a limb-specific, cis-acting regulator of Sonic hedgehog (Shh). Mamm. Genome 15:23-34
89. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-50
90. Croston GE, Cao Z, Goeddel DV. 1995. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 270:16514-17
91. Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128-31
92. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-46
93. Wasserman SA. 1993. A conserved signal transduction pathway regulating the activity of the rel-like proteins dorsal and NF-κB. Mol. Biol. Cell 4:767-71
94. Gay NJ, Keith FJ. 1991. Drosophila Toll and IL-1 receptor. Nature 351:355-56
95. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-22
96. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-29
97. Jiang Z, Mak TW, Sen G, Li X. 2004. Toll-like receptor 3-mediated activation of NF-κB and IRF-3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc. Natl. Acad. Sci. USA 101:3533-38
98. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, et al. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171:4304-10
99. Sakurai H, Miyoshi H, Toriumi W, Sugita T. 1999. Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation. J. Biol. Chem. 274:10641-48
100. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K, Gaynor RB. 2003. TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 326:105-15
101. Hoebe K, Du X, Goode J, Mann N, Beutler B. 2003. Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening. J. Endotoxin. Res. 9:250-55
102. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, et al. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:6668-72
103. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:161-71
104. Park JM, Greten FR, Li ZW, Karin M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-51
105. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. 2003. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J. Biol. Chem. 278:49751-62
106. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6:565-70
107. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, et al. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190-98
108. Calvo D, Dopazo J, Vega MA. 1995. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Genomics 25:100-6
109. Asch AS, Barnwell J, Silverstein RL, Nachman RL. 1987. Isolation of the thrombospondin membrane receptor 3. J. Clin. Invest. 79:1054-61
110. Abumrad NA, el Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36 1. J. Biol. Chem. 268:17665-68
111. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, et al. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:76-83
112. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. 1993. CD36 is a receptor for oxidized low density lipoprotein 2. J. Biol. Chem. 268:11811-16
113. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, et al. 2006. 3d, a missense mutation that disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7, and 9. Nat. Immunol. In press
114. + channel that coordinates muscle contraction in Caenorhabditis elegans. J. Neurosci. 23:9133-45
115. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, et al. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5:503-7
116. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. 2003. IKKε and TBK1 are essential components of the IRF-3 signaling pathway. Nat. Immunol. 4:491-96
117. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101:233-38
118. tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, et al. 2004. Activation of TBK1 and IKKε kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of Interferon antiviral immunity. J. Virol. 78:10636-49
119. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, et al. 2004. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-50
120. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, et al. 2004. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF-7 with MyD88 and TRAF6. Nat. Immunol. 5:1061-68
121. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-49
122. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202
123. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, et al. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-91
124. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, et al. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4:920-27
125. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, et al. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5:373-79
126. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21:227-39
127. Beutler B. 2004. SHIP, TGF-β, and endotoxin tolerance. Immunity 21:134-35
128. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, et al. 2003. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300:1584-87
129. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869-72
130. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, et al. 2004. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23:1587-97
131. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. 1996. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379:821-23
132. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
133. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99:8826-31
134. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73
135. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, et al. 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452-58
136. Goodnow CC, Sprent J, de St Groth BF, Vinuesa CG. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435:590-97